Hamed Hosseini
Tehran University of Medical Sciences
H-index: 23
Asia-Iran
Top articles of Hamed Hosseini
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Patient and physician perspectives in the management of immune thrombocytopenia in Iran: Responses from the ITP World Impact Survey (I-WISh) | Clinical and Applied Thrombosis/Hemostasis | Peyman Eshghi Hassan Abolghasemi Ali A Akhlaghi Farzaneh Ashrafi Mohammadreza Bordbar | 2023/1 |
Safety and immunogenicity of COReNAPCIN®, a SARS-CoV-2 mRNA vaccine; a randomized, double-blind, placebo-controlled phase 1 clinical trial | medRxiv | Mohammadreza Salehi Ilad Alavi Darazam Alireza Nematollahi Masoumeh Alimohammadi Sedigheh Pouya | 2023/11/2 |
Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial | bmj | Minoo Mohraz Katayoun Vahdat Seyyed-Hadi Ghamari Mohsen Abbasi-Kangevari Erfan Ghasemi | 2023/9/21 |
The protection quest is a primary key to sharing the neutralizing antibody response to cover against all emerging VOCs based on BIV1-CovIran studies | Heliyon | Maryam Shafaati Kowsar Bagherzadeh Majid Lotfinia Hesam Karimi Ali Teimoori | 2023/3/1 |
Efficacy and safety of “Jollab Monzej” as a traditional persian compound medicine for the treatment of multiple sclerosis-related fatigue: A randomized placebo-controlled trial | Caspian Journal of Internal Medicine | Fatemeh Yousefnia Babaki Mahmood Khodadoost Hossein Rezaeizadeh Abdorreza Naser Moghadasi Shirin Fahimi | 2023 |
Fresh-Packed RBC Infusion Diminishes Acute AlP Poisoned-Patients' Mortality Rate: A Clinical Trial | Acta Medica Iranica | Nastaran Rahimi Behnam Behnoush Hamed Hosseini Amir A Fakhrabadi Nina Javadian | 2022 |
Immunogenicity and Safety of a Variant-Specific COVID-19 Vaccine Booster, BIV1-Coviran Plus: Findings from a Non-Inferiority, Parallel-Design Non-Randomised Clinical Trial | BIV1-Coviran Plus: Findings from a Non-Inferiority, Parallel-Design Non-Randomised Clinical Trial | Minoo Mohraz Mohsen Abbasi-Kangevari Seyyed-Hadi Ghamari Erfan Ghasemi Mohammad-Reza Malekpour | 2023/1 |
A randomized, double-blind controlled clinical study to determine the effectiveness, safety and tolerability of actoferon (R) compared to betaferon (R) in subjects with … | Journal of Reports in Pharmaceutical Sciences | Shahla Mirzaeei Ashkan Barfar Saba Mehrandish Ali Ebrahimi | 2021/7/1 |
Immunogenicity and safety of a bivalent, adjuvant system 04-adjuvanted human papillomavirus vaccine in healthy female volunteers aged 15-25: a randomized, double-blind, phase … | European Journal of Cancer Prevention | Seyyedeh Maryam Afshani Reihaneh Mirhassani Hamed Hosseini Reihaneh Hosseini Afsaneh Tehranian | 2022/11/1 |
Assessment of BIV1-CovIran inactivated vaccine–elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern | Clinical Microbiology and Infection | Mohammadreza Salehi Hamed Hosseini Hamid Reza Jamshidi Hasan Jalili Payam Tabarsi | 2022/6/1 |
Evaluation of the Safety and Efficacy of a Biosimilar Abobotulinum Toxin Type A in Treating Moderate to Severe Glabellar Lines: A Non-Inferiority Double Blinded Randomized … | Journal of Cosmetic Dermatology | A. Afshani S.M. Samadi A. Ayatollahi | 2022 |
Effect of “Mehrpishegan” web-based support group on depression, anxiety, and stress among elderly informal caregivers: a protocol for a randomized-controlled trial | Trials | Fatemeh Rahimi Elham Shakibazadeh Mahnaz Ashoorkhani Hamed Hosseini Mahshid Foroughan | 2022/5/17 |
Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II … | BMJ open | Minoo Mohraz Mohammadreza Salehi Payam Tabarsi Mohsen Abbasi-Kangevari Seyyed-Hadi Ghamari | 2022/4/1 |
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARD: a case series. | Stem cell research & therapy | Seyed-Mohammad Reza Hashemian Rasoul Aliannejad Morteza Zarrabi Masoud Soleimani Massoud Vosough | 2021/12 |
COVID‐19 vaccines: what dermatologists should know? | Azin Ayatollahi Hamed Hosseini Rojin Firooz Alireza Firooz | 2021/9 | |
Another step toward final call on Remdesivir efficacy as a treatment for hospitalized COVID-19 patients: a multicenter open-label trial | MedRxiv | Hamed Hosseini Anahita Sadeghi Payam Tabarsi Azin Etemadimanesh Ilad Alavi Darazam | 2021/8/13 |
The effect of the mobile “blood pressure management application” on hypertension self-management enhancement: a randomized controlled trial | Trials | Ali Bozorgi Hamed Hosseini Hassan Eftekhar Reza Majdzadeh Ali Yoonessi | 2021/6/24 |
COVID-19 and dermatologists (5) | Hamed Hosseini Rojin Firooz Alireza Firooz | 2021/1/1 | |
Medical Sciences’ Students Responses During the Late Phase of the COVID-19 Pandemic in Iran: A Comprehensive Investigation of the Risk Perception and Information Exposure | Acta Medica Iranica | Mahan Shafie Mahsa Mayeli Hamed Hosseini Mahnaz Ashoorkhani | 2021/12/15 |
Effect of oral administration of Triphala, a polyphenol-rich prebiotic, on scalp sebum in patients with scalp seborrhea A Randomized Clinical Trial | Journal of Dermatological Treatment | Elham Zareie Parvin Mansouri Hamed Hosseini Omid Sadeghpour Laila Shirbeigi | 2020 |
Co-Authors
